Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1982 1
1984 1
1985 3
1988 1
1989 1
1990 1
1991 3
1993 1
1994 4
1995 5
1996 3
1997 3
1998 9
1999 4
2000 5
2001 3
2002 5
2003 1
2004 3
2005 4
2008 3
2009 4
2010 2
2011 3
2012 3
2013 3
2014 8
2015 4
2016 3
2017 1
2018 2
2019 2
2020 4
2021 5
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Splenic Lymphoblastic Lymphoma"
Page 1
Lymphoblastic lymphoma.
Cortelazzo S, Ponzoni M, Ferreri AJ, Hoelzer D. Cortelazzo S, et al. Crit Rev Oncol Hematol. 2011 Sep;79(3):330-43. doi: 10.1016/j.critrevonc.2010.12.003. Epub 2011 Jan 26. Crit Rev Oncol Hematol. 2011. PMID: 21273093 Review.
Lymphoblastic lymphoma (LBL) is a neoplasm of immature B cells committed to the B-(B-LBL) or T-cell lineage (T-LBL) that accounts for approximately 2% of all lymphomas. ...Although histological features are usually sufficient to distinguish lymphoblastic …
Lymphoblastic lymphoma (LBL) is a neoplasm of immature B cells committed to the B-(B-LBL) or T-cell lineage (T-LBL) tha …
B-cell Non-Hodgkin Lymphomas with Plasmacytic Differentiation.
Harmon CM, Smith LB. Harmon CM, et al. Surg Pathol Clin. 2016 Mar;9(1):11-28. doi: 10.1016/j.path.2015.09.007. Surg Pathol Clin. 2016. PMID: 26940265 Review.
Diagnostic challenges can arise in differentiating lymphoplasmacytic lymphoma from marginal zone lymphoma and other low-grade B-cell lymphomas. In addition, plasmablastic lymphomas can be difficult to distinguish from diffuse large B-cell lymphoma …
Diagnostic challenges can arise in differentiating lymphoplasmacytic lymphoma from marginal zone lymphoma and other low-grade …
Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.
Buchner M, Müschen M. Buchner M, et al. Curr Opin Hematol. 2014 Jul;21(4):341-9. doi: 10.1097/MOH.0000000000000048. Curr Opin Hematol. 2014. PMID: 24811161 Free PMC article. Review.
Here, we summarize the recent experimental evidence for the importance of BCR signaling and clinical concepts to target the BCR pathway in B-cell leukemia and lymphoma. RECENT FINDINGS: Although the dependency on pre-BCR signaling in pre-B acute lymphoblastic …
Here, we summarize the recent experimental evidence for the importance of BCR signaling and clinical concepts to target the BCR pathway in B …
Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH. Chan JK, et al. Blood. 1997 Jun 15;89(12):4501-13. Blood. 1997. PMID: 9192774 Free article. Review.
All of these patients died within 6 weeks. (3) In blastoid NK cell lymphoma (n = 2), the lymphoma cells resembled those of lymphoblastic or myeloid leukemia. ...Nonnasal CD56+ lymphomas are heterogeneous, but all pursue a highly aggressive clinical …
All of these patients died within 6 weeks. (3) In blastoid NK cell lymphoma (n = 2), the lymphoma cells resembled those …
Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer-Cell Neoplasms.
Shi Y, Wang E. Shi Y, et al. Arch Pathol Lab Med. 2015 Sep;139(9):1173-80. doi: 10.5858/arpa.2014-0079-RS. Arch Pathol Lab Med. 2015. PMID: 26317456 Free article. Review.
Hepatosplenic T-cell lymphoma is a rare, aggressive T-cell lymphoma, characterized by hepatosplenic sinusoidal infiltration of monotonous, medium-sized, nonactivated cytotoxic T cells, usually of gamma/delta T-cell receptor type. ...The differen …
Hepatosplenic T-cell lymphoma is a rare, aggressive T-cell lymphoma, characterized by hepatosplenic sinusoidal i …
LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.
Li J, Muhammad J, Xie T, Sun J, Lei Y, Wei Z, Pan S, Qin H, Shao L, Jiang D, Zhang Q. Li J, et al. Mol Immunol. 2021 Dec;140:267-275. doi: 10.1016/j.molimm.2021.10.016. Epub 2021 Nov 20. Mol Immunol. 2021. PMID: 34808497 Free article.
BACKGROUND: Leukemia is a group of hematopoietic malignancies characterized by the accumulation and infiltration of abnormal hematopoietic stem cells or early progenitor cells. T cell acute lymphoblastic leukemia (T-ALL) is a hematologic malignancy occurring in 15 % …
BACKGROUND: Leukemia is a group of hematopoietic malignancies characterized by the accumulation and infiltration of abnormal hematopoietic s …
Lymphoma--emerging realities in sub-Saharan Africa.
Sissolak G, Juritz J, Sissolak D, Wood L, Jacobs P. Sissolak G, et al. Transfus Apher Sci. 2010 Apr;42(2):141-50. doi: 10.1016/j.transci.2010.01.009. Epub 2010 Feb 10. Transfus Apher Sci. 2010. PMID: 20149748
This was followed by 32 months for those with mantle cell (n=7), splenic (n=2) and extranodal marginal cell (n=11), 24 months for T-cell lymphomas (n=24), 20 months for diffuse large B-cell variants (n=88) but only 12 months for the aggressive t …
This was followed by 32 months for those with mantle cell (n=7), splenic (n=2) and extranodal marginal cell (n=11), 24 …
Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma.
Ikeda JI, Kohara M, Tsuruta Y, Nojima S, Tahara S, Ohshima K, Kurashige M, Wada N, Morii E. Ikeda JI, et al. Hum Pathol. 2017 Jan;59:70-79. doi: 10.1016/j.humpath.2016.09.011. Epub 2016 Sep 22. Hum Pathol. 2017. PMID: 27666766
Marginal zone lymphoma (MZL) is a low-grade B-cell lymphoma derived from marginal zone B cells. ...Other mature B-cell and T-cell lymphomas, and Hodgkin lymphoma were negative for IRTA1. ...
Marginal zone lymphoma (MZL) is a low-grade B-cell lymphoma derived from marginal zone B cells. ...Other mature B-ce …
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia.
Capello D, Vitolo U, Pasqualucci L, Quattrone S, Migliaretti G, Fassone L, Ariatti C, Vivenza D, Gloghini A, Pastore C, Lanza C, Nomdedeu J, Botto B, Freilone R, Buonaiuto D, Zagonel V, Gallo E, Palestro G, Saglio G, Dalla-Favera R, Carbone A, Gaidano G. Capello D, et al. Blood. 2000 Jan 15;95(2):651-9. Blood. 2000. PMID: 10627476 Free article.
On the basis of a comprehensive analysis of 308 B-cell neoplasms, we (1) expand the spectrum of tumors associated with BCL-6 mutations; (2) corroborate the notion that mutations cluster with GC and post-GC B-cell neoplasms; and (3) identify heterogeneous mutation fr …
On the basis of a comprehensive analysis of 308 B-cell neoplasms, we (1) expand the spectrum of tumors associated with BCL-6 mutation …
Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
Moore EM, Swerdlow SH, Gibson SE. Moore EM, et al. Am J Surg Pathol. 2018 Mar;42(3):342-350. doi: 10.1097/PAS.0000000000001015. Am J Surg Pathol. 2018. PMID: 29309299
Its role in the differential diagnosis of B-cell lymphomas, particularly in the distinction of follicular lymphoma (FL) versus marginal zone lymphoma (MZL), remains to be determined. ...MEF2B was positive in all FL and Burkitt lymphomas, 8/9 mantle cell …
Its role in the differential diagnosis of B-cell lymphomas, particularly in the distinction of follicular lymphoma (FL) versus …
104 results